Seeing Is Believing
RPRX is currently covered by 3 analysts with an average price target of $57.22. This is a potential upside of $12.97 (29.31%) from yesterday's end of day stock price of $44.25.
Royalty Pharma Plc's activity chart (see below) currently has 78 price targets and 50 ratings on display. The stock rating distribution of RPRX is 80% BUY and 20% HOLD.
Analysts average stock forecasts to be materialized ratio is 16.17% with an average time for these price targets to be met of 284.67 days.
Highest price target for RPRX is $54, Lowest price target is $49, average price target is $51.
Most recent stock forecast was given by ASHWANI VERMA from UBS on 30-Jan-2026.
Currently out of the existing stock ratings of RPRX, 4 are a BUY (80%), 1 are a HOLD (20%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 03-Jun-2024
$49
$4.35 (9.74%)
$28
13 days ago
(30-Jan-2026)
3/6 (50%)
$7.32 (17.56%)
632
Buy Since 13-Jul-2020
$50
$5.35 (11.98%)
$42
16 days ago
(27-Jan-2026)
2/5 (40%)
$9.53 (23.55%)
384
Buy Since 06-Apr-2022
$54
$9.35 (20.94%)
$54
4 months 2 days ago
(10-Oct-2025)
2/19 (10.53%)
$17.99 (49.96%)
457
Buy Since 29-Oct-2021
$40
$-4.65 (-10.41%)
$60
1 years 3 months 18 days ago
(25-Oct-2024)
1/4 (25%)
$13.78 (52.56%)
376
Buy Since 27-Apr-2022
$51
$6.35 (14.22%)
$50
1 years 5 months 29 days ago
(14-Aug-2024)
0/4 (0%)
$25.27 (98.21%)
What is RPRX (Royalty Pharma Plc) average time for price targets to be met?
Which analyst has the current highest performing score on RPRX (Royalty Pharma Plc) with a proven track record?
Which analyst has the current lower performing score on RPRX (Royalty Pharma Plc) with a proven track record?
Which analyst has the most public recommendations on RPRX (Royalty Pharma Plc)?
Which analyst is the currently most bullish on RPRX (Royalty Pharma Plc)?
Which analyst is the currently most reserved on RPRX (Royalty Pharma Plc)?